These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28798290)

  • 21. Efficacy, safety and tolerability of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections.
    Ferwerda A; Moll HA; Hop WC; Kouwenberg JM; Tjon Pian Gi CV; Robben SG; de Groot R
    J Antimicrob Chemother; 2001 Apr; 47(4):441-6. PubMed ID: 11266417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment.
    Coles CL; Mabula K; Seidman JC; Levens J; Mkocha H; Munoz B; Mfinanga SG; West S
    Clin Infect Dis; 2013 Jun; 56(11):1519-26. PubMed ID: 23487375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical studies of azithromycin, a new macrolide antibiotic, for infections in the field of surgery].
    Nakayama I
    Jpn J Antibiot; 2000 Jun; 53 Suppl B():82-90. PubMed ID: 12572091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypothermia from azithromycin.
    Kavukçu S; Uğuz A; Aydin A
    J Toxicol Clin Toxicol; 1997; 35(2):225-6. PubMed ID: 9120898
    [No Abstract]   [Full Text] [Related]  

  • 25. Sensorineural hearing loss as a probable serious adverse drug reaction associated with low-dose oral azithromycin.
    Mick P; Westerberg BD
    J Otolaryngol; 2007 Oct; 36(5):257-63. PubMed ID: 17963663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter randomized study of two once daily regimens in the initial management of community-acquired respiratory tract infections in 163 children: azithromycin versus ceftibuten.
    Galova K; Sufliarska S; Kukova Z; Danisovicova A; Hrachova I; Grausova S; Marinova I; Krizan S; Stopkova K; Stahorska A; Durcanska K; Raskova J; Krupova I; Krcméry V
    Chemotherapy; 1996; 42(3):231-4. PubMed ID: 8983893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia.
    Kohno S; Tateda K; Kadota J; Fujita J; Niki Y; Watanabe A; Nagashima M
    J Infect Chemother; 2014 Mar; 20(3):199-207. PubMed ID: 24477328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
    McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The comparison of single-dose ceftriaxone, five-day azithromycin, and ten-day amoxicillin/clavulanate for the treatment of children with acute otitis media.
    Biner B; Celtik C; Oner N; Küçükuğurluoğlu Y; Güzel A; Yildirim C; Adali MK
    Turk J Pediatr; 2007; 49(4):390-6. PubMed ID: 18246740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Severe neutropenia as side effect of medical treatment in nontuberculous mycobacterial adenitis].
    Ruíz del Olmo I; Romera B; Guerrero C; Burgués P; Bustillo M
    Rev Chilena Infectol; 2015 Oct; 32(5):584-7. PubMed ID: 26633119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Azithromycin and the risk of cardiovascular complications.
    Maisch NM; Kochupurackal JG; Sin J
    J Pharm Pract; 2014 Oct; 27(5):496-500. PubMed ID: 25374989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative evaluation of 2 g single dose versus conventional dose azithromycin in uncomplicated skin and skin structure infections.
    Dey SK; Das AK; Sen S; Hazra A
    Indian J Pharmacol; 2015; 47(4):365-9. PubMed ID: 26288467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in QT intervals after azithromycin-containing antibiotic therapy in patients with NTM lung disease.
    Shin B; Park HY; Koh WJ
    Int J Tuberc Lung Dis; 2014 Nov; 18(11):1385. PubMed ID: 25299875
    [No Abstract]   [Full Text] [Related]  

  • 34. Azithromycin. A review of its use in paediatric infectious diseases.
    Langtry HD; Balfour JA
    Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of intravenous azithromycin followed by oral azithromycin for the treatment of acute pelvic inflammatory disease and perihepatitis in Japanese women.
    Mikamo H; Iwasaku K; Yamagishi Y; Matsumizu M; Nagashima M
    J Infect Chemother; 2014 Jul; 20(7):429-35. PubMed ID: 24787738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and effectiveness of azithromycin in the treatment of respiratory infections in children.
    Lakoš AK; Pangerčić A; Gašparić M; Kukuruzović MM; Kovačić D; Baršić B
    Curr Med Res Opin; 2012 Jan; 28(1):155-62. PubMed ID: 22070514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin.
    Chandra R; Liu P; Breen JD; Fisher J; Xie C; LaBadie R; Benner RJ; Benincosa LJ; Sharma A
    Clin Pharmacokinet; 2007; 46(3):247-59. PubMed ID: 17328583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of QT-interval prolongation precipitated by azithromycin.
    Matsunaga N; Oki Y; Prigollini A
    N Z Med J; 2003 Nov; 116(1185):U666. PubMed ID: 14615808
    [No Abstract]   [Full Text] [Related]  

  • 39. Enhanced hypoprothrombinemia with warfarin due to azithromycin.
    Rao KB; Pallaki M; Tolbert SR; Hornick TR
    Ann Pharmacother; 2004 Jun; 38(6):982-5. PubMed ID: 15084685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis.
    Protzko E; Bowman L; Abelson M; Shapiro A;
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3425-9. PubMed ID: 17652708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.